COMPARING WHITE LIGHT VERSUS BLUE LIGHT CYSTOSCOPY RECURRENCE OUTCOMES AMONG NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS IN AN EQUAL ACCESS SETTING: A PROPENSITY SCORED MATCHED ANALYSIS

被引：0
|
作者：
Sanjay, Das
William, Aronson
Ali, Nasrallah
Stephen, Williams B.
Trustram, Eve Claire
Lin, Gu
Joshua, Parrish
Amanda, De Hoedt M.
Chad, Mckee
Stephen, Freedland J.
机构：
[1] UCLA Hlth, Los Angeles, CA USA
[2] Univ Texas Med Branch, Galveston, TX USA
[3] Durham VA Hlth Care Syst, Durham, NC USA
[4] Photocure Inc, Princeton, NJ USA
[5] Cedars Sinai Med Ctr, Los Angeles, CA USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.200
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
163
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [41] Blue light cystoscopy versus white light cystoscopy for the detection of bladder cancer in China: An analysis of unpublished clinical trial and real-world data.
    Li, Hanzhong
    Hu, Hailong
    Ma, Lulin
    Guo, Jianming
    Liu, Xiuheng
    Huang, Jian
    Guo, Yonglian
    Wen, Jin
    Zhang, Shudong
    Zhang, Hongxian
    Jiang, Shuai
    Liu, Cheng
    He, Wang
    Kang, Xinli
    Wang, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 593 - 593
  • [42] ONE YEAR RECURRENCE RATES IN NON-MUSCLE INVASIVE BLADDER CANCER AFTER HAL CYTOSCOPY AND TURBT - THE IMPACT OF BLUE LIGHT IN THE LONG RUN
    Geavlete, B.
    Multescu, R.
    Georgescu, D.
    Jecu, M.
    Geavlete, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 644 - 645
  • [43] HEXAMINOLEVULINATE BLUE-LIGHT FLEXIBLE CYSTOSCOPY IN ADDITION TO STANDARD WHITE-LIGHT CYSTOSCOPY IN THE FOLLOW-UP OF NON-MUSCLE INVASIVE BLADER CANCER: COST-CONSEQUENCES DURING OUTPATIENT SURVEILLANCE IN SWEDEN
    Dansk, V
    Malmstrom, P.
    Blackberg, M.
    Malmenas, M.
    VALUE IN HEALTH, 2015, 18 (07) : A354 - A354
  • [44] THE IMPACT OF BLUE-LIGHT CYSTOSCOPY ON RESPONSE TO INDUCTION BCG IN PATIENTS WITH HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER
    Mikkilineni, Nina
    Antoine, Samuel
    Alford, Ashley
    Li, Gen
    Wenske, Sven
    Decastro, G. Joel
    McKiernan, James
    Anderson, Christopher
    JOURNAL OF UROLOGY, 2018, 199 (04): : E98 - E98
  • [45] IS A RESTAGINGTURBT NECESSARY IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER IF THE INITIAL TURBT WAS PERFORMED USING BLUE LIGHT?
    Alsyouf, Muhannad
    Seyedian, Sanam Ladi
    Konety, Badrinath
    Pohar, Kamal
    Holzbeierlein, Jeffrey M.
    Kates, Max
    Willard, Brian
    Taylor, Jennifer M.
    Liao, Joseph C.
    Kaimakliotis, Hristos Z.
    Porten, Sima P.
    Steinberg, Gary D.
    Tyson, Mark D.
    Lotan, Yair
    Daneshmand, Siamak
    JOURNAL OF UROLOGY, 2022, 207 (05): : E258 - E258
  • [46] A prospective, randomized comparison between the hexaminolevulinate blue light and the standard white light cystoscopy concerning the long term recurrence rates in nonmuscle invasive bladder cancer cases
    Geavlete, B.
    Multescu, R.
    Stanescu, F.
    Georgescu, D.
    Jecu, M.
    Moldoveanu, C.
    Geavlete, P. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E955 - U6
  • [47] RISKS AND BENEFITS OF FREQUENT SURVEILLANCE CYSTOSCOPY AMONG PATIENTS WITH LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Schroeck, Florian
    Lynch, Kristine
    Li, Zhongze
    MacKenzie, Todd
    Seigne, John
    Han, David
    Robertson, Douglas
    Sirovich, Brenda
    Goodney, Philip
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1202 - E1203
  • [48] A cost-consequences and budget impact analysis of blue light-guided cystoscopy with Hexvix in patients diagnosed with non-muscle-invasive bladder cancer in France
    Belsey, Jonathan
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1398 - 1406
  • [49] Effects of fluorescent light cystoscopy in non-muscle-invasive bladder cancer: A systematic review and meta-analysis
    Sun, Jiazhu
    Ma, Xueyou
    Shen, Haixiang
    Liu, Ben
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 34
  • [50] FLEXIBLE BLUE LIGHT CYSTOSCOPY WITH HEXAMINOLEVULINATE PROVIDES OPPORTUNITY TO FINALIZE DIAGNOSIS AND TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER IN THE OUTPATIENT CLINIC. RESULTS FROM A NORDIC REGISTRY
    Edwin, Gorm von Gohren
    Debes, Anders
    Malmstrom, Per-Uno
    JOURNAL OF UROLOGY, 2019, 201 (04): : E619 - E619
12345